4MOVING Biotech
Clinical-stage biotech developing intra-articular GLP-1 therapy 4P004 for knee osteoarthritis patients
Highlights
- New on EvolcAdded 2026-11-11
About 4MOVING Biotech
4Moving Biotech develops 4P004, a clinical-stage therapy for osteoarthritis that uses GLP-1 analogs to target low-grade inflammation and joint structures such as cartilage, subchondral bone and synovium.
The company is developing the product for patients with osteoarthritis and is pursuing regulatory and trial approaches that include in-silico trials and AI-driven patient selection.
The company is registered in Lille, France, as a SAS founded in 2020. Its website lists Phase 2a enrollment in the INFLAM MOTION study, a FDA Fast Track designation for 4P004 in April 2026, and a leadership team that includes co-founders Revital Rattenbach and Prof. Francis Berenbaum.
Product: 4P004, an intra-articular GLP-1 analog therapy for osteoarthritis, currently in Phase 2 clinical development.
Jobs at 4MOVING Biotech
More biotech & pharma companies
4P-Pharma
Clinical-stage biotech developing drug candidates for serious diseases with unmet medical needsAb Science
Develops pharmaceutical compounds for clinical programs in neurology, inflammatory diseases, oncology and viral diseasesAbbelight
Bioimaging platform, reagents and software for life-science researchers doing 3D super-resolution microscopyAbcely
Develops oral sIgA immunotherapies for mucosal cancers and other mucosal diseasesYoung companyNew on EvolcAbivax
Develops obefazimod and other therapeutics for patients with chronic inflammatory diseasesABL
Molecular diagnostic assays, sequencing analysis software and specimen collection kits for clinical labs, researchers and hospitals
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.